Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Herpes Zoster Ophthalmicus: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Herpes Zoster Ophthalmicus: 1 US clinical trial tracked, none currently recruiting.

Herpes Zoster Ophthalmicus is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is NYU Langone Health, running 1 of these trials.

Enrollment posture brief

Registry condition herpes-zoster-ophthalmicus

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Herpes Zoster Ophthalmic (th…0%
Open-enrollment share among volume-matched conditions near Herpes Zoster Ophthalmicus

Herpes Zoster Ophthalmicus has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Herpes Zoster Ophthalmicus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Herpes Zoster Ophthalmicus is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Herpes Zoster Ophthalmicus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Masked Oral Valacyclovir Drug
1 trials
Masked Placebo Drug
1 trials

US sites by state

Facility locations filed on Herpes Zoster Ophthalmicus trials. A trial with sites in several states counts in each.

Indiana 1 trials
Illinois 1 trials
Georgia 1 trials
Florida 1 trials
Colorado 1 trials
California 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Herpes Zoster Ophthalmicus page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Herpes Zoster Ophthalmicus trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • NYU Langone Health sponsors the most Herpes Zoster Ophthalmicus trials on record, review their full trial history before evaluating a specific study. See NYU Langone Health's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Herpes Zoster Ophthalmicus condition card totals 1 registered trials; most-linked intervention Masked Oral Valacyclovir; top US site state Indiana. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.